+
Site Tour

Reconsidering current approaches to valve and LVAD therapies

Key topics:
-Epic Plus Mitral is a suitable platform for MICS delivering favourable outcomes – M. Loubani
-Better hemodynamic outcomes can be achieved with Epic Max – T. Holubec
-Surgical assessment and technical strategies to overcome more challenging patient characteristics when implanting LVADs – A. Loforte
-The impact of avoiding Aspirin in HeartMate 3 LVAD patients: results from the ARIES trial – I.Netuka

Related Videos

TAVI Summit - Live case from Berlin

Now you've got Navitor.
Stable delivery.

Now you've got Navitor.
Future ready.

TAVI Summit - Cardiac imaging

TAVI Summit - TAVR in bicuspid

TAVI Summit - TAVR in bicuspid

TAVI Summit - Cardiac imaging and morphology

TRENDING TOPICS

Early outcomes on Epic Max platform

Cleveland clinic (US) experience: Early outcomes and a perspective on porcine vs. bovine

Transfemoral TAVI

Navitor Vision 35 implantation

Webinar PFO closure in patients >60 Years

Webinar PFO closure with Amplatzer™ Talisman™ PFO Occluder in patients >60 years

CONNEXT


HUB

CONNEXT


LIVE
RELATED EVENTS

TAVI Summit - Cardiac imaging and morphology

TAVI Summit - Live case from Berlin

TAVI Summit - Cardiac imaging

TAVI Summit - TAVR in bicuspid

You are about to leave my-connext.com

You are now leaving my-connext.com. Abbott is not responsible for any content published on the third-party website you are about to enter. Abbott has not reviewed and does not endorse any information presented on third-party websites.

The content on this website is intended for healthcare professionals in EMEA with applicable health authority product registrations, excepted those practicing in France as some of the content is not in compliance with the French Advertising law N°2011-2012 dated 29th December 2011 article 34. Click OK to confirm you are a healthcare professional to proceed.

OK Decline